deucravacitinib,Apremilast
bms,amgen
['psoriasis', 'deucrava', 'deucra', '$bmy']
$bmy [15s. delayed]: issued press release on september 09, 22:38:00: u.s. food and drug administration approves sotyktu (deucravacitinib), oral treatment for adults with moderate-to-severe plaque psoriasis 
Flash Alert is a low-latency financial news service which sources SEC, press releases, credible news sources to get your news about stocks in near real-time